JohnLBerkMD
Pulmonology • Boston, MACritical Care Medicine, Pleural Disease
Associate Professor of Medicine, Boston University
Dr. Berk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
725 Albany St
# Shapiro
Boston, MA 02118Phone+1 617-638-7480Fax+1 617-638-7486
Education & Training
Boston University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1987 - 1991
University of California (San Diego) Medical CenterResidency, Internal Medicine, 1985 - 1985
Case Western Reserve University/University Hospitals Cleveland Medical CenterInternship, Internal Medicine, 1983 - 1984
Case Western Reserve University School of MedicineClass of 1983
Certifications & Licensure
MA State Medical License 1987 - 2025
OH State Medical License 1986 - 1990
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- Boston Magazine Castle Connolly, 2009-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- The Effect of Diflunisal on Familial Amyloidosis Start of enrollment: 2006 Feb 01
- Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis Start of enrollment: 2010 Nov 01
- Safety and Effect of Doxycycline in Patients With Amyloidosis Start of enrollment: 2012 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- Correction: Switching from inotersen to eplontersen in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: analysis from NEURO-TTRansform.Isabel Conceição, John L Berk, Markus Weiler, Pedro A Kowacs, Noel R Dasgupta
Journal of Neurology. 2025-02-03 - Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label Extension.David Adams, Jonas Wixner, Michael Polydefkis, John L Berk, Isabel M Conceição
JAMA Neurology. 2025-01-13 - 21 citationsVutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy.Marianna Fontana, John L Berk, Julian D Gillmore, Ronald M Witteles, Martha Grogan
The New England Journal of Medicine. 2025-01-02
Journal Articles
- Unusual Duplication Mutation in a Surface Loop of Human Transthyretin Leads to an Aggressive Drug-Resistant Amyloid DiseaseJohn L Berk, Paul J Kurtin, Proceedings of the National Academy of Sciences
- Inotersen Treatment for Patients with Hereditary Transthyretin AmyloidosisWilliam J Litchy, Peter D Gorevic, Morie A Gertz, Amil M Shah, John L Berk, Peter J Dyck, The New England Journal of Medicine
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin AmyloidosisPeter J Dyck, John L Berk, The New England Journal of Medicine
Press Mentions
Faculty Promotions Announced, May 2021August 17th, 2021- Intellia, with First Results, Delivers a 'Landmark' for CRISPR Gene EditingJune 26th, 2021
Hear from the Experts on Hereditary AmyloidosisJune 3rd, 2019- Join now to see all
Grant Support
- Effect Of Diflunisal (IND68092) On Familial AmyloidosisNational Institute Of Neurological Disorders And Stroke2005–2009
- The Effect Of Diflunisal On Hereditary AmyloidosisNational Center For Research Resources2007
- Effect Of Diflunisal On Familial AmyloidosisFood And Drug Administration2006–2007
- Adrenal Insufficiency In Primary Systemic AmyloidosisNational Center For Research Resources1999–2001
- Retinoids And Collagen Transcription In Lung FibroblastsNational Heart, Lung, And Blood Institute1996–1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
